174 related articles for article (PubMed ID: 12683352)
1. Circulating tumor cells and serum tumor biomarkers in small cell lung cancer.
Ma PC; Blaszkowsky L; Bharti A; Ladanyi A; Kraeft SK; Bruno A; Skarin AT; Chen LB; Salgia R
Anticancer Res; 2003; 23(1A):49-62. PubMed ID: 12683352
[TBL] [Abstract][Full Text] [Related]
2. Biomarker discovery in lung cancer--promises and challenges of clinical proteomics.
Bharti A; Ma PC; Salgia R
Mass Spectrom Rev; 2007; 26(3):451-66. PubMed ID: 17407130
[TBL] [Abstract][Full Text] [Related]
3. Haptoglobin alpha-subunit and hepatocyte growth factor can potentially serve as serum tumor biomarkers in small cell lung cancer.
Bharti A; Ma PC; Maulik G; Singh R; Khan E; Skarin AT; Salgia R
Anticancer Res; 2004; 24(2C):1031-8. PubMed ID: 15154618
[TBL] [Abstract][Full Text] [Related]
4. Markers of small cell lung cancer.
Taneja TK; Sharma SK
World J Surg Oncol; 2004 May; 2():10. PubMed ID: 15128454
[TBL] [Abstract][Full Text] [Related]
5. A "live" biopsy in a small-cell lung cancer patient by detection of circulating tumor cells.
Bevilacqua S; Gallo M; Franco R; Rossi A; De Luca A; Rocco G; Botti G; Gridelli C; Normanno N
Lung Cancer; 2009 Jul; 65(1):123-5. PubMed ID: 19261349
[TBL] [Abstract][Full Text] [Related]
6. Value of tumour and inflammatory markers in lung cancer.
Oremek GM; Sauer-Eppel H; Bruzdziak TH
Anticancer Res; 2007; 27(4A):1911-5. PubMed ID: 17649794
[TBL] [Abstract][Full Text] [Related]
7. ProGRP: a new biomarker for small cell lung cancer.
Molina R; Filella X; Augé JM
Clin Biochem; 2004 Jul; 37(7):505-11. PubMed ID: 15234231
[TBL] [Abstract][Full Text] [Related]
8. Prognosis of non-small cell lung cancer patients by detecting circulating cancer cells in the peripheral blood with multiple marker genes.
Sher YP; Shih JY; Yang PC; Roffler SR; Chu YW; Wu CW; Yu CL; Peck K
Clin Cancer Res; 2005 Jan; 11(1):173-9. PubMed ID: 15671543
[TBL] [Abstract][Full Text] [Related]
9. [Detection and clinic implication of circulating tumor cell in patients with lung cancer].
Mu XL; Li LY
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Jun; 26(3):313-8. PubMed ID: 15266838
[TBL] [Abstract][Full Text] [Related]
10. [Role of the cut-off value of serum neuron-specific enolase in differentiating small cell lung cancer from non-small cell lung cancer].
Wei T; Luo RC; Zuo Q; Zhang JY; Miao JX; Lu HF
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jun; 26(6):858-9. PubMed ID: 16793621
[TBL] [Abstract][Full Text] [Related]
11. [The estimation of serum concentration of vascular endothelial growth factor in patients with non-small cell lung cancer].
Kopczyńska E; Dancewicz M; Kowalewski J; Kardymowicz H; Tyrakowski T
Pol Merkur Lekarski; 2007 Jun; 22(132):536-8. PubMed ID: 17874624
[TBL] [Abstract][Full Text] [Related]
12. Fuzzy logic-based tumor marker profiles including a new marker tumor M2-PK improved sensitivity to the detection of progression in lung cancer patients.
Schneider J; Peltri G; Bitterlich N; Neu K; Velcovsky HG; Morr H; Katz N; Eigenbrodt E
Anticancer Res; 2003; 23(2A):899-906. PubMed ID: 12820320
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic relevance of circulating biomarkers in patients with lung cancer.
Molina R; Holdenrieder S; Auge JM; Schalhorn A; Hatz R; Stieber P
Cancer Biomark; 2010; 6(3-4):163-78. PubMed ID: 20660962
[TBL] [Abstract][Full Text] [Related]
14. Biomarkers for lung cancer: clinical uses.
Greenberg AK; Lee MS
Curr Opin Pulm Med; 2007 Jul; 13(4):249-55. PubMed ID: 17534168
[TBL] [Abstract][Full Text] [Related]
15. Sensitive detection of small cell lung carcinoma cells by reverse transcriptase-polymerase chain reaction for prepro-gastrin-releasing peptide mRNA.
Saito T; Kobayashi M; Harada R; Uemura Y; Taguchi H
Cancer; 2003 May; 97(10):2504-11. PubMed ID: 12733150
[TBL] [Abstract][Full Text] [Related]
16. Soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) detection in cancer patients: a prognostic marker for lung metastases from solid malignancies.
Karapanagiotou EM; Pelekanou E; Charpidou A; Tsaganos T; Anagnostou V; Plachouras D; Giamarellos-Bourboulis EJ; Syrigos KN
Anticancer Res; 2008; 28(2B):1411-5. PubMed ID: 18505088
[TBL] [Abstract][Full Text] [Related]
17. SCG3 transcript in peripheral blood is a prognostic biomarker for REST-deficient small cell lung cancer.
Moss AC; Jacobson GM; Walker LE; Blake NW; Marshall E; Coulson JM
Clin Cancer Res; 2009 Jan; 15(1):274-83. PubMed ID: 19118055
[TBL] [Abstract][Full Text] [Related]
18. Comparison of serum growth factors and tumor markers as prognostic factors for survival in non-small cell lung cancer.
Nieder C; Andratschke N; Jeremic B; Molls M
Anticancer Res; 2003; 23(6D):5117-23. PubMed ID: 14981976
[TBL] [Abstract][Full Text] [Related]
19. Serum levels of interleukin-18 (IL-18) and soluble interleukin-2 receptor (sIL-2R) in lung cancer.
Naumnik W; Chyczewska E; Kovalchuk O; Tałałaj J; Izycki T; Panek B
Rocz Akad Med Bialymst; 2004; 49():246-51. PubMed ID: 15631351
[TBL] [Abstract][Full Text] [Related]
20. Human small cell lung cancer cells express functional VEGF receptors, VEGFR-2 and VEGFR-3.
Tanno S; Ohsaki Y; Nakanishi K; Toyoshima E; Kikuchi K
Lung Cancer; 2004 Oct; 46(1):11-9. PubMed ID: 15364128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]